Curative Biotechnology, Inc.?: Curative Biotechnology Announ

Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-stage biomedical company focused on novel treatments for rare

Related Keywords

, Paul Michaels , Steve Chizzik , Boca Raton , Development Agreement , Securities Exchange , Michaels , Curative Biotechnology Inc , Investigational New Drug , Toxicology Study , Topical Instillation , Curative Biotechnology , Intermediate Dry Age Related Macular Degeneration , Geographical Atrophy , Cooperative Research , National Eye Institute , National Institutes , Bethesda Maryland , Macular Degeneration , Geographic Atrophy , Curative Biotech , Age Related Macular Degeneration , Securities Act , Securities Exchange Act , Curative , Biotechnology , Nnounces , Completion , Nabling , Eformulated , Metformin , Drop , Study ,